N1-Methylsulfonyl pseudouridine, a purine nucleoside analogue, exhibits broad antitumor activity, particularly against indolent lymphoid malignancies. Its anticancer mechanisms include the inhibition of DNA synthesis and the induction of apoptosis, among others [1].